Online webinar - available on-demand
Across the industry, pharmaceutical companies are using AI to streamline compliance, reduce deviations, accelerate batch release and improve decision-making. However, as AI adoption grows, so does regulatory scrutiny.
The question is no longer whether regulators will ask about AI, it’s what they will want to know when they do.
RSSL have partnered with Martin Lush to bring you this insightful and timely webinar. With 44 years of experience in the pharmaceutical industry and recognised expertise in applying AI within GxP environments, Martin is widely respected for his practical, common-sense approach to AI. He has helped educate current and former regulators across the UK, US, EU and APAC on how to assess and audit AI applications.
Most recently, Martin asked 40 corporate auditors, including former regulatory inspectors, with more than 300 years of combined experience, to identify the questions they would ask about AI in GxP environments.
For each question he will explain:
Whether you are a QP responsible for batch release, a QA Manager building AI governance, or a Quality Director setting strategy, these are the questions your team needs to be prepared for.
Martin Lush
Martin is one of the pharmaceutical industry's most recognised voices on the practical application of AI in GMP-regulated environments. Formerly Global VP of Pharma, Biotech and Medical Devices at NSF, Martin now works with pharmaceutical organisations worldwide, helping quality, operations and leadership teams adopt AI safely, compliantly, and effectively.
His insights are drawn from hands-on work with more than 25 pharmaceutical companies actively using AI and his courses have been attended by current and former regulatory inspectors.
RSSL has partnered with Martin to bring this highly regarded training to our course portfolio - combining his industry-leading expertise in AI for pharma with our 30+ years of experience in pharmaceutical professional development.
